Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001815572-25-000017
Filing Date
2025-04-14
Accepted
2025-04-14 14:28:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8068
2 13G EXHIBIT 99.1 PDF acmex99.pdf EX-99.1 95280
  Complete submission text file 0001815572-25-000017.txt   141221
Mailing Address 804 EAST GATE DR., SUITE 200 MT. LAUREL NJ 08054
Business Address 804 EAST GATE DR., SUITE 200 MT. LAUREL NJ 08054 856-505-8800
INTEST CORP (Subject) CIK: 0001036262 (see all company filings)

EIN.: 222370659 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-51325 | Film No.: 25835509
SIC: 3825 Instruments For Meas & Testing of Electricity & Elec Signals
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1452 HUGHES ROAD SUITE 200 #582 GRAPEVINE TX 76051
Business Address 1452 HUGHES ROAD SUITE 200 #582 GRAPEVINE TX 76051 682-553-8302
ASKELADDEN CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001815572 (see all company filings)

EIN.: 810803834 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SCHEDULE 13G